PLOD3 and metastatic malignant neoplasm in the lymph nodes: This association becomes particularly evident when analyzing specific clinical subgroups, N1 + N2 group with lymph node metastasis, M1 group with distant metastasis, and III + IV tumor stage group all exhibited significantly greater levels of PLOD3 expression (Fig. S1D–F).